Status
ACTIVE
Global HQ
Hong Kong, Hong Kong
Countries of investment
- China
- Hong Kong
- Singapore
- Japan
- United Kingdom
- Sweden
- Italy
- United States
- Australia
Investment stages
- Seed
- Series A
- Series B
- Series C
- Growth
Industries
- Technology
- AI
- Robotics
- Enterprise Software
- Health Tech
- Biotechnology
- Consumer Products
- E-Commerce
- Energy Storage
About
HSG, formerly known as Sequoia China, is a leading venture capital and private equity firm investing globally across technology, healthcare, and consumer sectors. With offices in Hong Kong, Shanghai, Beijing, Shenzhen, London, Tokyo, and Singapore, HSG manages over USD 61 billion in assets for institutional investors, as of June 30, 2026. Since its founding in 2005, HSG has backed more than 1,700 companies led by entrepreneurs building transformative technologies and category-defining businesses. To date, more than 180 HSG portfolio companies have gone public, and over 140 have reached unicorn status.
HSG, formerly known as Sequoia China, is a leading venture capital and private equity firm investing globally across technology, healthcare, and consumer sectors. With offices in Hong Kong, Shanghai, Beijing, Shenzhen, London, Tokyo, and Singapore, HSG manages over USD 61 billion in assets for institutional investors, as of June 30, 2026. Since its founding in 2005, HSG has backed more than 1,700 companies led by entrepreneurs building transformative technologies and category-defining businesses. To date, more than 180 HSG portfolio companies have gone public, and over 140 have reached unicorn status.
Investment Thesis
HSG invests globally across technology, healthcare, and consumer sectors, backing founders from seed through growth and beyond. The firm operates a fully integrated platform spanning seed, venture, growth, buyout, and infrastructure investing, alongside public equities. HSG supports portfolio companies with industry expertise and access to an entrepreneurial community built over two decades. Since its founding in 2005, HSG has backed more than 1,700 companies, of which over 180 have gone public.
Manager's Experience
Founded in 2005 as Sequoia Capital China by Neil Shen (Founding and Managing Partner, BSc in applied mathematics from Shanghai Jiao Tong University, master's from Yale School of Management, previously an investment banker at Lehman Brothers and Deutsche Bank, co-founder of Ctrip and Home Inn) together with Zhang Fan, who left in 2009. Manages over USD 61B as of June 30, 2026, and has backed more than 1,800 companies, over 190 of which have gone public and over 140 became unicorns. Portfolio includes Alibaba, Ant Group, Airwallex, Amer Sports, AgiBot, Agile Robots, AgileX Robotics, 3SBio, and AbelZeta Pharma. Offices in Hong Kong, Beijing, Shanghai, Shenzhen, Singapore, London, and Tokyo. Invests in technology, healthcare, and consumer companies from seed to buyout, infrastructure, and public equities.
Team
Neil Shen - Founding & Managing Partner
Kui Zhou - Senior Partner
Xing Liu - Partner
Tiantian He - Partner
Cherry Lu - Partner
Cen Wang - Partner
Luca Schmid - Managing Director
Haiyuan (Chris) Miao - Partner & Head of Human Capital
Brian Y. - Executive Director
Portfolio
Alibaba Group
ByteDance
Meituan
Pinduoduo
JD.com
Didi
NIO
BYD
Xpeng
Airwallex
Canva
Monzo
DJI
Pop Mart
Ant Group
Agile Robots
Amer Sports
ZTO Express
Moderna
ArriVent BioPharma